USE OF FAVIPIRAVIR IN THE MANAGEMENT OF COVID-192020-08-26T18:32:11+02:00Jul 22nd, 2020|MAC Advisories|Advisory on Favipiravir-22 July 2020Rapid Review of Favipiravir for COVID-19_25June2020facebooktwitterlinkedinwhatsappEmail Related Posts PROPOSAL FOR ALERT LEVEL 2 MANAGING OUTBREAKS IN HEALTHCARE FACILITIES SEROLOGICAL TESTING FOR SARS-COV-2 RECOMMENDATIONS FOR USE OF SARS-CoV-2 ANTIBODY TESTING
